Friday, September 30, 2022
8:00 a.m. – 12:30 p.m.
Canine Bacterial Pneumonia: Rethinking an Old Disease
This lecture will cover bacterial pneumonia etiology, focusing on the two most common causes: community-acquired infections and aspiration pneumonia. Preventative strategies, diagnostics, and treatment will be discussed. Strategies for dogs with and without clear evidence of a bacterial infection will be described, including controversies surrounding length of antimicrobial administration and metrics to monitor response to therapy and guide length of treatment.
Pharmacologic Management of Respiratory Disease
Respiratory diseases make up a large proportion of veterinary visits in both dogs and cats, with clinical signs including nasal discharge, sneezing, stertor, stridor, wheeze, cough, tachypnea, labored respiration, exercise intolerance, and cyanosis. Medical management can at times be challenging and strategies are diverse depending on the underlying condition. In this lecture, pharmacologic management of several broad categories of disorders will be discussed, with an emphasis on therapeutic goals.
Pulmonary Hypertension in Dogs Caused by Non-Cardiac Disease
Pulmonary hypertension—abnormal increases in pulmonary vascular pressures—is a hemodynamic and pathologic state that occurs secondary to a wide variety of cardiac, vascular, respiratory, and even systemic disorders, and causes morbidity and mortality in dogs. Material from the American College of Veterinary Internal Medicine’s recent guidelines for diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs will be presented. This lecture will focus on causes of pulmonary hypertension that are unrelated to left ventricular dysfunction or valvular disease.
Respiratory Diseases You May Not Have Learned in Veterinary School
Advances are being made in all fields of veterinary medicine, with respiratory medicine being no exception. This lecture will focus on updates on relatively “new” respiratory disorders, inclusive of diagnostic modalities that have allowed for identification and characterization of these discoveries. Five major groups of disease will be covered: dynamic upper airway disorders, aspiration-related respiratory syndromes, bronchiolar (small airway) disease, interstitial lung disease, and pulmonary vascular disorders.